Li-Bo Tang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 3
- Cancer Genomics and Diagnostics 2
- MicroRNA in disease regulation 2
-
- Lung Cancer Treatments and Mutations 2
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Lixia Xiong (3 shared papers)Xingning Lai (1 shared paper)Wen‐Tong Chen (1 shared paper)Lei Zhang (1 shared paper)Qing-Yun Huang (1 shared paper)Guofeng Liu (1 shared paper)Xianling Qian (1 shared paper)Chuangye Han (2 shared papers)
- Journals
- Cancers (2 papers)Clinica Chimica Acta (1 paper)Current Molecular Medicine (1 paper)Translational Lung Cancer Research (1 paper)International Journal of Medical Sciences (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Li-Bo Tang
12 papers receiving 214 citations
Peers
Comparison fields: 5 of 49
- Cancer Research 105
- Molecular Biology 120
- Neurology 19
- Pulmonary and Respiratory Medicine 35
- Oncology 21
Countries citing papers authored by Li-Bo Tang
This map shows the geographic impact of Li-Bo Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Bo Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Bo Tang more than expected).
Fields of papers citing papers by Li-Bo Tang
This network shows the impact of papers produced by Li-Bo Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Bo Tang. The network helps show where Li-Bo Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Li-Bo Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 68 | |
| 2 | 2019 | 45 | |
| 3 | 2021 | 30 | |
| 4 | 2020 | 23 | |
| 5 | 2023 | 10 | |
| 6 | 2021 | 9 | |
| 7 | 2025 | 8 | |
| 8 | 2023 | 8 | |
| 9 | 2020 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2021 | 2 | |
| 13 | 2024 | 0 | |
| 14 | 2024 | 0 | |
| 15 | 2025 | 0 |
About Li-Bo Tang
Li-Bo Tang is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Infectious Diseases, having authored 15 papers that have together received 215 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Lung Cancer Research Studies (2 papers), Cancer Genomics and Diagnostics (2 papers), COVID-19 and healthcare impacts (2 papers), Circular RNAs in diseases (2 papers), Lung Cancer Treatments and Mutations (2 papers), MicroRNA in disease regulation (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (105 citations), Molecular Biology (120 citations), Neurology (19 citations), Pulmonary and Respiratory Medicine (35 citations) and Oncology (21 citations). Li-Bo Tang has collaborated with scholars based in China and United States. Frequent co-authors include Lixia Xiong, Xingning Lai, Wen‐Tong Chen, Lei Zhang, Qing-Yun Huang, Guofeng Liu, Xianling Qian, Chuangye Han, Shuqi Zhao and Dalang Fang. Their work appears in journals such as Cancers, Clinica Chimica Acta, Current Molecular Medicine, Translational Lung Cancer Research and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.